Cardiologists Warn of Risks After Stopping Weight-Loss Drugs

Cardiologists are raising concerns about the potential health risks, including rapid weight regain and cardiovascular stress, for patients stopping Ozempic or Mounjaro.

Recent studies indicate that patients who discontinue these GLP-1 injections without a structured transition plan often experience a 'yo-yo' effect on their metabolic health.

Medical experts advise patients to consult with their doctors before stopping treatment to manage potential side effects like skin pain and increased appetite.